Busy FDA gives rare disease sector complementary pathways, unanswered questions – 2026 snapshot on June 08, 2026 Accelerated Approval Disease Evidence Principles Fast Track Infrequent mechanism pathway Orphan Drug Designation Pediatric Disorder Rare Diseases RDEP Review Voucher United States Food and Drug Administration +